This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Dividend Stocks Ready to Give You a Raise


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

It's been a good year for biotechnology giant Amgen (AMGN - Get Report); shares of the $69 billion firm have rallied close to 40% since the start of 2012. While Amgen may not get the attention of some of its big(ger) pharma peers, the firm is a blockbuster maker, with more than five drugs under its belt that each bring in over $1 billion in annual sales.

Currently, Amgen pays out a 36-cent quarterly dividend, adding up to a 1.6% yield at current price levels. Now I think this firm is due to give investors a raise.

>>4 Biotech Stocks Under $10 Moving Higher

Amgen's expertise in biotechnology-based therapeutics is unique among firms its size. It gives the firm an advantage over smaller rivals in the amount of capital it's able to throw at a project. Like its more traditional peers, the firm does face risks from patent drop-offs over the next few years, but it also boasts an attractive pipeline of around 20 new drug compounds. That pipeline should help to make up for generic competition on Amgen's existing drugs.

Meanwhile, the company is generating tons of cash. Around a third of each sales dollar Amgen earns gets converted into free cash, the result of hefty profit margins and economies of scale in Amgen's business. That free cash gives Amgen plenty of ammunition for a dividend hike this quarter.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AET $96.56 2.40%
AMGN $142.90 -0.07%
F $11.28 -2.70%
MAT $30.89 -3.30%
MKC $88.40 0.60%


Chart of I:DJI
DOW 15,911.28 -115.77 -0.72%
S&P 500 1,838.07 -15.37 -0.83%
NASDAQ 4,236.5620 -47.1910 -1.10%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs